Compare Injective (INJ) vs Raydium (RAY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Injective vs Raydium — how do they compare? Injective trades at Rp81,164 (market cap Rp8,14T, Rp740,53M 24h volume), while Raydium trades at Rp11,162 (market cap Rp2,98T, Rp111,91M 24h volume). The key difference: Injective is far larger — about 2.7× Raydium's market cap, and Raydium's supply is capped (269,5M / 555M RAY (49%)) while Injective's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Injective for 37 Days and Raydium for 25 Days on average.
| INJ | RAY | |
|---|---|---|
Market Cap | Rp8,14T | Rp2,98T |
Volume (24h) | Rp740,53M | Rp111,91M |
Circulating Supply | 100M INJ | 269,5M / 555M RAY (49%) |
Typical Hold Time | 37 Days | 25 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
INJ is currently trading at Rp81,847 with a market cap of Rp8.18 trillion, showing bearish technical signals with moving averages indicating selling pressure while oscillators remain neutral. The token faces immediate resistance at Rp82,576 with support at Rp81,456. Recent on-chain data shows an average hold time of 37 days, suggesting moderate holding patterns among investors.
Overall outlook remains cautious with technical indicators favoring bearish momentum. Key opportunities include potential bounce from support levels, while major risks involve continued selling pressure and crypto market volatility. Investors should monitor network adoption metrics and exchange liquidity closely.
RAY is currently trading at Rp11,213 with a market cap of Rp3 trillion, showing bearish technical signals with moving averages indicating selling pressure while oscillators remain neutral. The token has achieved significant milestones including surpassing Rp1 quadrillion in trading volume following major exchange listings on Robinhood and Revolut. Recent protocol developments include enabling 24/7 tokenized stock trading for the SpaceX IPO on Solana, expanding RAY's utility as a liquidity protocol.
Overall outlook remains cautious due to bearish technical indicators, though recent exchange listings and protocol innovations present growth opportunities. Key risks include high volatility near resistance levels and regulatory uncertainty around tokenized securities. Investors should monitor RSI levels and trading volume patterns for entry signals.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Injective
Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.
Read more on INJ →About Raydium
Raydium (RAY) is an automated market maker (AMM) and liquidity provider built on the Solana blockchain for the Serum decentralized exchange (DEX). Unlike any other AMMs, Raydium provides on-chain liquidity to a central limit orderbook meaning that funds deposited into Raydium are converted into limit orders which sit on Serum’s orderbooks.
Read more on RAY →
